111In-pentetreotide scintigraphy in the detection of insulinomas: Importance of SPECT imaging

O. Schillaci, R. Massa, F. Scopinaro

Research output: Contribution to journalArticlepeer-review


The aim of this study was to determine whether the systematic use of SPECT can increase the reported low sensitivity of somatostatin receptor scintigraphy (SRS) in detecting insulinomas. Methods: Fourteen patients were evaluated. After 111Inpentetreotide injection (~250 MBq intravenously), abdominal SPECT images were obtained at 4 h and multiple planar images were obtained at 4 and 24 h. MRI and CT were performed within 1 mo of SRS. Sixteen tumors were histologically verified after surgery in 14 patients. Results: SPECT revealed 14 lesions in 12 patients (sensitivity, 87.5%), both planar SRS and MRI revealed 7 tumors in 7 patients (sensitivity, 43.8%), and CT revealed only 5 lesions in 4 patients (sensitivity, 31.3%). Moreover, in 4 patients SPECT was the only examination with positive findings. Conclusion: SPECT at 4 h is mandatory for preoperative detection of insulinomas using SRS because the images are more sensitive than planar images and are superior to images from other conventional methods.

Original languageEnglish
Pages (from-to)459-462
Number of pages4
JournalJournal of Nuclear Medicine
Issue number3
Publication statusPublished - 2000


  • Insulinomas
  • Somatostatin receptor scintigraphy

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology


Dive into the research topics of '111In-pentetreotide scintigraphy in the detection of insulinomas: Importance of SPECT imaging'. Together they form a unique fingerprint.

Cite this